The Trump administration has reached an agreement with researchers and Democratic-led states who filed a lawsuit over cuts to diversity-related research funding at the National Institutes of Health (NIH). The deal, announced Monday, allows stalled or rejected grant applications to move forward for review after months of legal uncertainty surrounding diversity, equity, and inclusion (DEI) research funding.
The dispute began after the NIH canceled hundreds of millions of dollars in research grants, citing concerns that the projects were tied to DEI initiatives rather than core scientific objectives. In response, affected researchers and states sued the federal government, arguing that the funding cuts were unlawful and arbitrary. Earlier this year, U.S. District Judge William Young ruled in Boston that the NIH had improperly terminated the grants, finding that the cancellations violated federal law.
However, the legal battle became more complex in August when the U.S. Supreme Court partially paused Judge Young’s ruling. The high court determined that claims related to the terminated grants should be heard by a specialized federal court that handles monetary disputes with the government. At the same time, the Supreme Court left unresolved a separate issue regarding how the NIH handled applications for future research funding.
Monday’s agreement addresses that unresolved portion of the case. Under the deal, the federal government has agreed to conduct new reviews of grant applications that were frozen, denied, or withdrawn after the policy change was announced. Importantly, the agreement does not require the NIH to approve or fund any specific research proposals, but it does reopen the door for fair consideration.
The researchers involved say the affected grants cover critical public health areas, including HIV prevention, Alzheimer’s disease, LGBTQ health, and sexual violence research. One of the plaintiffs, Nikki Maphis, a postdoctoral researcher at the University of New Mexico, welcomed the development, saying it allows her Alzheimer’s and aging brain research to move forward after what she described as an “arbitrary and destructive freeze.”
The agreement does not affect Judge Young’s earlier ruling blocking the NIH policy itself. The U.S. Department of Health and Human Services has appealed that decision and maintains that it ended funding for research it believes prioritized ideology over scientific rigor.


Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
California Drops Lawsuit Over Federal Funding Cuts to High-Speed Rail Project
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Administration Recalls Nearly 30 U.S. Ambassadors in Push for “America First” Agenda
Epstein Files Released by DOJ Spotlight Bill Clinton, Raise Questions Over Trump Mentions
Israel’s Recognition of Somaliland Sparks U.N. Debate and Regional Tensions
NSW Passes Toughest Gun and Anti-Terror Laws After Bondi Beach Shooting
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Najib Razak Awaits Court Rulings in 1MDB Case as Malaysia’s Anti-Graft Drive Faces Test
Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial
South Korea Prosecutor Alleges Former First Lady Kim Keon Hee Abused Power for Bribes
Bolsonaro Undergoes Phrenic Nerve Block Procedure After Surgery-Related Complications
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Brazil Court Allows Bolsonaro Hospital Trip Amid Prison Sentence 



